| Ethan Westbrook, DO | |
|
800 Garfield Ave Rm G102, Parkersburg, WV 26101-5340 | |
| (304) 424-4575 | |
| (304) 424-4577 |
| Full Name | Ethan Westbrook |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 800 Garfield Ave Rm G102, Parkersburg, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124514054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 3581 (West Virginia) | Secondary |
| 207R00000X | Internal Medicine | 3581 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Medical Center | Logan, WV | Hospital |
| Jackson General Hospital | Ripley, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Care Alliance, Inc. | 5799689105 | 18 |
News Archive
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
University of North Carolina Lineberger Comprehensive Cancer Center researchers are reporting the concluding findings from a major analysis of nearly 10,000 different tumor samples that focused on identifying similarities between cancers based on changes in their genes, and the way their genes are expressed.
Many groups fear, or are fiercely advocating for, provisions in Democratic health care reform proposals. Others are softening their stances on certain parts of the bills. Here's a sampling from today's clippings.
› Verified 1 days ago
| Entity Name | Community Health Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649277476 PECOS PAC ID: 1759291313 Enrollment ID: O20031219000784 |
News Archive
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
University of North Carolina Lineberger Comprehensive Cancer Center researchers are reporting the concluding findings from a major analysis of nearly 10,000 different tumor samples that focused on identifying similarities between cancers based on changes in their genes, and the way their genes are expressed.
Many groups fear, or are fiercely advocating for, provisions in Democratic health care reform proposals. Others are softening their stances on certain parts of the bills. Here's a sampling from today's clippings.
› Verified 1 days ago
| Entity Name | Hospital Development Co. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790745677 PECOS PAC ID: 4183527476 Enrollment ID: O20040406000528 |
News Archive
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
University of North Carolina Lineberger Comprehensive Cancer Center researchers are reporting the concluding findings from a major analysis of nearly 10,000 different tumor samples that focused on identifying similarities between cancers based on changes in their genes, and the way their genes are expressed.
Many groups fear, or are fiercely advocating for, provisions in Democratic health care reform proposals. Others are softening their stances on certain parts of the bills. Here's a sampling from today's clippings.
› Verified 1 days ago
| Entity Name | Health Care Alliance, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730128760 PECOS PAC ID: 5799689105 Enrollment ID: O20050816000292 |
News Archive
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
University of North Carolina Lineberger Comprehensive Cancer Center researchers are reporting the concluding findings from a major analysis of nearly 10,000 different tumor samples that focused on identifying similarities between cancers based on changes in their genes, and the way their genes are expressed.
Many groups fear, or are fiercely advocating for, provisions in Democratic health care reform proposals. Others are softening their stances on certain parts of the bills. Here's a sampling from today's clippings.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ethan Westbrook, DO 800 Garfield Ave Rm G102, Parkersburg, WV 26101-5340 Ph: (304) 424-4575 | Ethan Westbrook, DO 800 Garfield Ave Rm G102, Parkersburg, WV 26101-5340 Ph: (304) 424-4575 |
News Archive
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
University of North Carolina Lineberger Comprehensive Cancer Center researchers are reporting the concluding findings from a major analysis of nearly 10,000 different tumor samples that focused on identifying similarities between cancers based on changes in their genes, and the way their genes are expressed.
Many groups fear, or are fiercely advocating for, provisions in Democratic health care reform proposals. Others are softening their stances on certain parts of the bills. Here's a sampling from today's clippings.
› Verified 1 days ago
Dr. Hemant Modi, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 18th St, Suite 512, Parkersburg, WV 26101 Phone: 304-424-4574 Fax: 304-424-4429 | |
John A. Goddard, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 18th St, Suite 512, Parkersburg, WV 26101 Phone: 304-424-4574 Fax: 304-424-4429 | |
Dr. Robert Timothy Hogan Ii, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2777 | |
John V Onestinghel Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1907 Ann St, Parkersburg, WV 26101 Phone: 304-424-4205 Fax: 304-424-4485 | |
Sumaira Shafi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2111 | |
Elizabeth S Powers, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3 Rosemar Cir, Suite D, Parkersburg, WV 26104 Phone: 304-865-7700 Fax: 304-865-7703 | |
David Alan Gnegy, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 18th St, Suite 512, Parkersburg, WV 26101 Phone: 304-424-4574 Fax: 304-424-4429 |